This Week’s Biotech Highlights
Citius, Altius, Fortius. Let me join the (undoubtedly numerous) others appropriating olympic symbolism this week. In this case, the olympic motto (Swifter, Higher, Stronger) happens to be a timely way to summarize this week’s biotech news.
Citius:Matthew Herper at Forbes called for faster communication to investors when companies deviate from their agreed clinical trial plan with the FDA. Herper suggested that the FDA should disclose the actual agreements with the companies; but I argued that as with any other material information, it is the company’s job to communicate with its investors.


